We represented Wayspring, formerly Axial Healthcare, in its $75 million investment from Valtruis, Centene Corporation, CareSource, HLM Venture Partners and other leading investors. Wayspring will use the capital to scale its value-based care solution, a full-risk medical home model for substance use disorder (SUD).
